Mr Jonathan B Skidmore > Norton Rose Fulbright > Dallas, United States > Lawyer Profile
Norton Rose Fulbright Offices
2200 ROSS AVENUE
SUITE 3600
DALLAS, TX 75201-7932
TEXAS
United States
- Firm Profile
- Go to...
Mr Jonathan B Skidmore
Work Department
Life Sciences, Pharma and Healthcare Litigation
Career
https://nortonrosefulbright.com/en-us/people/1000782
Lawyer Rankings
United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
D’Lesli M Davis heads up Norton Rose Fulbright‘s Texas-based life sciences and healthcare group that has national reach and provides comprehensive representation of clients in the sector in the defense of high-stakes litigation, as well as in relation to drug safety mandates. The team often has a lead role in large consolidated actions and MDLs and is able to marshal resources from its broader overarching product liability, mass torts and commercial litigation teams should the need arise. As well as handling conventional personal injury-related matters, Davis has been particularly effective in positioning the firm at the very pinnacle of cases relating to economic loss, not only behalf of affected consumers but also third party payers. Jonathan B Skidmore is noted for his trial expertise, as well as his ability to strategize in large-scale mass torts in the life sciences space, and senior associate Ellie Norris continues to impress for her pivotal work on big-ticket litigation, including on the discovery side, as well as working alongside expert and fact witnesses to ensure they persuasively advance the defense narrative.
United States > Healthcare > Life sciences
Norton Rose Fulbright’s team advises biotech and bioscience companies, and retail pharmacies on routine merger clearances, ITC proceedings, and claims arising from data security breaches and privacy violations. D’Lesli M. Davis leads the team from Dallas alongside Jonathan B. Skidmore. Davis acts as trial counsel on behalf of medical device and pharmaceutical clients in mass tort cases and product liability litigation, while Skidmore handles a broad range of issues including drug safety, marketing, and discoveries. In the New York office, David Kessler heads the domestic data and information risk practice, advising clients on safe data storage and the integration of record retention. Also based in New York, Robin Adelstein acts as the US head for antitrust and competition at the firm, routinely assisting life sciences and pharmaceutical companies on M&A, trade association activities, and government investigations.
Lawyer Rankings
- Product liability, mass tort and class action - defense: pharmaceuticals and medical devices United States > Dispute resolution
- Life sciences United States > Healthcare
Top Tier Firm Rankings
Firm Rankings
- Transport > Aviation and air travel: finance
- Dispute resolution > E-discovery
- Industry focus > Education
- Energy > Energy litigation: oil and gas
- Energy > Energy transactions: oil and gas
- Dispute resolution > International litigation
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Finance > Restructuring (including bankruptcy): municipal
- Transport > Shipping: finance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Energy > Energy regulation: electric power
- Energy > Energy transactions: electric power
- Dispute resolution > International arbitration
- Dispute resolution > Product liability, mass tort and class action - defense: automotive/transport
- Finance > Structured finance: securitization
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
- Antitrust > Civil litigation/class actions: defense
- Environment > Environment: litigation
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Tax > International tax
- Labor and employment > Labor and employment disputes (including collective actions)
- Healthcare > Life sciences
- Media, technology and telecoms > Outsourcing
- Intellectual property > Patents: litigation (full coverage)
- Finance > Restructuring (including bankruptcy): corporate
- Healthcare > Service providers
- Real estate > Real estate
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)